catalyst · primary record

DAPAGLIFLOZIN

FDA filing · 2026-10-01

Company	SCIEGEN PHARMACEUTICALS INC
Ticker	Not stated
Impact	medium
Detail	Original Application · Tentative Approval
Source	openFDA

Provenance

Source: openFDA
Fetched at: 2026-11-03T00:35:04.007Z
Licence class: attribution-required
Verdict: primary-source
Entity id: SCIEGEN PHARMACEUTICALS INC:DAPAGLIFLOZIN:2026-10-01:Original Application · Tentative Approval

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.